Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Rhythm Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier:
NCT01394055
First received: July 8, 2011
Last updated: March 6, 2013
Last verified: March 2013